GSK promotes local clinical trials in Korea

Published: 2009-06-04 06:58:00

Updated: 2009-06-04 06:58:00

GlaxoSmithKline plc has boosted its intensive clinical studies in Korea by focusing on three core therapeutic fields, such as oncology, neuroscience and respiratory disease, according to its Korea unit.

GSK Korea conducted a total of 64 clinical trials designed to develop new drugs and vaccine...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK